How Much Trouble Is Bed Bath & Beyond in After Preliminary Q4 Data?

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
How Much Trouble Is Bed Bath & Beyond in After Preliminary Q4 Data?

© iStock / Getty Images

Bed Bath & Beyond Inc. (NASDAQ: BYND) shares were crushed on Wednesday after the company announced its preliminary fourth-quarter results. Judging by the investor reaction alone, the results were not good at all.

The company reported results for the first two months of its fiscal fourth quarter. In this time, comparable sales declined by 5.4%, reflecting a low-double-digit percentage decrease in transactions in stores, partially offset by a mid-single-digit percentage increase in the average transaction amount.

On a directional basis, comparable sales from stores declined nearly 11%, while comparable sales from digital channels grew approximately 20%.

It’s also worth pointing out that comparable sales include the shift of the Cyber Monday holiday week, which is in the company’s fiscal fourth quarter this year versus the fiscal third quarter of last year. Adjusting for the calendar shift to exclude Cyber Monday week in both periods, comparable sales for these first two months declined 13%.

Look for the full earnings report after the market close on Wednesday, April 15, 2020.

[nativounit]

Mark J. Tritton, president and CEO of Bed Bath & Beyond, commented:

We are experiencing short-term pain in our efforts to stabilize the business, including the pressures of store traffic trends coupled with our own executional challenges.  However, we did achieve a notable positive shift in sales in our digital channels during this period, with growth of approximately 20%.  I believe we can solidify this growth, while also addressing the broader stabilization of our business.

Shares of Bed Bath & Beyond traded down nearly 27% to $10.90 on Wednesday, in a 52-week range of $7.31 to $19.57. The consensus price target is $14.62.

[recirclink id=644657]
[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618